These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3141292)

  • 1. Fulminant NANB hepatitis in a patient with AIDS: a possible demonstration of direct hepatic damage by the virus/es involved?
    Libanore M; Bicocchi R; Sighinolfi L; Ghinelli F
    Infection; 1988; 16(4):255. PubMed ID: 3141292
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problem of mixed infections in viral hepatitis].
    Farber NA
    Ter Arkh; 1985; 57(2):68-71. PubMed ID: 3923643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute pancreatitis associated with non-A-non-B hepatitis. Report of a case.
    Eugene C; Cadranel JF; Bergue A; Anciaux ML
    J Clin Gastroenterol; 1990 Apr; 12(2):195-7. PubMed ID: 2109006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological markers and antibody responses in fulminant viral hepatitis.
    Bal V; Amin SN; Rath S; Kamat SA; Zuckerman AJ; Marathe SN; Kamat RS
    J Med Virol; 1987 Sep; 23(1):75-82. PubMed ID: 3119769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection.
    Abrescia N; D'Abbraccio M; Figoni M; Busto A; Butrico E; De Marco M; Viglietti R
    J Antimicrob Chemother; 2002 Nov; 50(5):763-5. PubMed ID: 12407142
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of correlation between fulminant form of viral hepatitis and retrovirus infection associated with the acquired immune deficiency syndrome (AIDS) in drug addicts.
    Amoroso P; Lettieri G; Giorgio A; Fico P; Pierri P; Giraldo G; Beth-Giraldo E
    Br Med J (Clin Res Ed); 1986 Feb; 292(6517):376-7. PubMed ID: 3080178
    [No Abstract]   [Full Text] [Related]  

  • 7. Sporadic non-A, non-B hepatitis and Epstein-Barr hepatitis associated with the Guillain-Barré syndrome.
    Macleod WN
    Arch Neurol; 1987 Apr; 44(4):438-42. PubMed ID: 3030246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant viral hepatitis.
    Fagan EA; Williams R
    Br Med Bull; 1990 Apr; 46(2):462-80. PubMed ID: 2116214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of non-A, non-B hepatitis in children with acute leukemia and chronic liver disease.
    Locasciulli A; Alberti A; Barbieri R; Realdi G; Uderzo C; Portmann B; Masera G
    Am J Dis Child; 1983 Apr; 137(4):354-6. PubMed ID: 6402922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-A, non-B hepatitis.
    Ozsoylu S
    Am J Dis Child; 1984 Jan; 138(1):101-2. PubMed ID: 6419582
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-A, non-B (NANB) hepatitis. The extent of the problem.
    Foutch PG; Sanowski RA; Bellapravalu S
    Ariz Med; 1984 Dec; 41(12):796-8. PubMed ID: 6440521
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-A, non-B fulminant hepatitis is also non-E and non-C.
    Kuwada SK; Patel VM; Hollinger FB; Lin HJ; Yarbough PO; Wiesner RH; Kaese D; Rakela J
    Am J Gastroenterol; 1994 Jan; 89(1):57-61. PubMed ID: 8273799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemically silent posttransfusion non-A, non-B hepatitis interferes with superinfection by hepatitis A virus.
    Bradley DW; Krawczynski K; Humphrey CD; McCaustland KA
    Intervirology; 1987; 27(2):86-90. PubMed ID: 2822600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulminant hepatic failure following bone marrow transplantation for hepatitis-associated aplastic anemia.
    Van Dam J; Farraye FA; Gale RP; Zeldis JB
    Bone Marrow Transplant; 1990 Jan; 5(1):57-60. PubMed ID: 2105142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal varicella hepatitis in a patient with AIDS.
    Soriano V; Bru F; González-Lahoz J
    J Infect; 1992 Jul; 25(1):107. PubMed ID: 1522315
    [No Abstract]   [Full Text] [Related]  

  • 16. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses.
    Liang TJ; Jeffers L; Reddy RK; Silva MO; Cheinquer H; Findor A; De Medina M; Yarbough PO; Reyes GR; Schiff ER
    Gastroenterology; 1993 Feb; 104(2):556-62. PubMed ID: 8381099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses.
    Horvath J; Raffanti SP
    Clin Infect Dis; 1994 Mar; 18(3):339-47. PubMed ID: 8011813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythroderma with fulminant hepatitis: a possible association.
    Schwartz RA; Leevy CM; Cohen PJ; Lambert WC
    Cutis; 1986 Jan; 37(1):56-8. PubMed ID: 2936580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between hepatotropic viruses in patients with haemophilia.
    Lee CA; Kernoff PB; Karayiannis P; Farci P; Thomas HC
    J Hepatol; 1985; 1(4):379-84. PubMed ID: 3932510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatobiliary manifestations in acquired immunodeficiency syndrome].
    Urbain D
    Acta Urol Belg; 1993; 61(1-2):513-6. PubMed ID: 8517267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.